MMRF PRESS RELEASES
Annual Multiple Myeloma Research Foundation (MMRF) Chicago Awards Dinner Raises More Than $800,000 to Accelerate a Cure for Blood Cancer
New Canaan, Conn. — April 5, 2006
Chicago Bears Football Legend, Gale Sayers, and Actor and Director Bonnie Hunt Joined Forces for the Cause
The Multiple Myeloma Research Foundation (MMRF) last night raised more than $800,000 to support its mission of accelerating a cure for multiple myeloma, the second most common blood cancer, at its fifth Chicago Awards Dinner at the Four Seasons Hotel in Chicago.
Chicago Bears football legend, Gale Sayers, provided the evening's keynote address, highlighting the inspirational story of courage and friendship between himself and teammate, Brian Piccolo, who battled cancer. Actor, director and long time MMRF friend, Bonnie Hunt, a former oncology nurse, juxtaposed her witty humor with seriousness to bring attention to the cause, serving as mistress of ceremonies.
"Chicago continues to show great generosity and support in helping the MMRF achieve its goal," said Nancy Sumberaz, president of the MMRF. "We also are proud that more than 95 percent of the money raised tonight will go directly towards innovative research programs that will expedite the development of new and effective treatment options for multiple myeloma."
Sayers and Hunt joined Corporate Vice Chairs, Joseph M. Hogan of GE Healthcare, Lester B. Knight of RoundTable Healthcare Partners and Philip J. Purcell, retired Chairman and CEO of Morgan Stanley for the event. This line- up also was supported by an extensive list of Dinner Chairs including: Pam and Joe Damico; Jane and Bob DeBaun; Brian J. Feltzin of Sheffield Asset Management, LLC; Ron K. Labrum of Cardinal Health; Lee I. Miller of DLA Piper Rudnick Gray Cary; Michael D. O'Halleran of Aon Re Global; William A. Osborn of Northern Trust Corporation; Robert L. Parkinson, Jr. of Baxter International, Inc.; Edward J. Phillips of Edward and Leslye Phillips Family Foundation; David P. Purcell of Continental Advisors, LLC; J. Christopher Reyes of Reyes Holdings, LLC; Michael J. Sacks of Grosvenor Capital Management, L.P.; and, Perry J. Snyderman of Shell Vacations, LLC.
About Multiple Myeloma
Multiple myeloma, an incurable cancer of the plasma cell, represents one percent of all cancer diagnosis and two percent of all cancer deaths. Despite recent advances in treating multiple myeloma, the five-year survival rate for multiple myeloma is only 32 percent, one of the lowest of all cancers. Approximately 50,000 people in the United States are living with multiple myeloma and an estimated 16,000 new cases are diagnosed each year. Although the peak age of onset of multiple myeloma is 65 to 70 years of age, recent statistics suggest that incidence is increasing and at an earlier age.
About the Multiple Myeloma Research Foundation
The Multiple Myeloma Research Foundation (MMRF) was established in 1998 as a 501(c)3 non-profit organization by twin sisters Karen Andrews and Kathy Giusti, a newly diagnosed multiple myeloma patient, with the unique mission of accelerating the search for a cure for multiple myeloma. As the world's number one funder of myeloma research, the MMRF has raised more than $55 million to fund more than 130 research grants at more than 70 research institutions around the globe. Currently, the MMRF is funding more than 30 new compounds and approaches -- in pre-clinical testing and Phase I, II and III clinical trials -- that show promise in treating patients at all stages of the disease. For more information about the MMRF, please visit www.themmrf.org.
Multiple Myeloma Research Foundation